BRLI has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Cash flow for capital expenditures refers to the cash generated minus spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.
Bio-Reference Laboratories Inc's cash flow for capital expenditures for the three months ended in Apr. 2015 was $-11.6 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Apr. 2015 was $-24.2 Mil.
Bio-Reference Laboratories Inc Cash Flow for Capital Expenditures for the trailing twelve months (TTM) ended in Apr. 2015 was -4.018 (Jul. 2014 ) + -4.457 (Oct. 2014 ) + -4.149 (Jan. 2015 ) + -11.59 (Apr. 2015 ) = $-24.2 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Bio-Reference Laboratories Inc Annual Data
Bio-Reference Laboratories Inc Quarterly Data